These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 8782209)
1. Mutant p53 expression in kidney tubules adjacent to renal cell carcinoma: evidence of a precursor lesion. Lai R; el Dabbagh L; Mourad WA Mod Pathol; 1996 Jun; 9(6):690-5. PubMed ID: 8782209 [TBL] [Abstract][Full Text] [Related]
2. p53 and HER-2 alterations in renal cell carcinoma. Zhang XH; Takenaka I; Sato C; Sakamoto H Urology; 1997 Oct; 50(4):636-42. PubMed ID: 9338750 [TBL] [Abstract][Full Text] [Related]
3. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification. Zhou M; Yang XJ; Lopez JI; Shah RB; Hes O; Shen SS; Li R; Yang Y; Lin F; Elson P; Sercia L; Magi-Galluzzi C; Tubbs R Am J Surg Pathol; 2009 Dec; 33(12):1840-9. PubMed ID: 19898225 [TBL] [Abstract][Full Text] [Related]
4. p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus. Bian YS; Osterheld MC; Bosman FT; Benhattar J; Fontolliet C Mod Pathol; 2001 May; 14(5):397-403. PubMed ID: 11353048 [TBL] [Abstract][Full Text] [Related]
5. Detection of p53 and bcl-2 protein in carcinoma of the renal pelvis and ureter including dysplasia. Furihata M; Sonobe H; Ohtsuki Y; Yamashita M; Morioka M; Yamamoto A; Terao N; Kuwahara M; Fujisaki N J Pathol; 1996 Feb; 178(2):133-9. PubMed ID: 8683378 [TBL] [Abstract][Full Text] [Related]
6. p53 expression in human renal cell carcinoma: an immunohistochemical study and a literature outline of the cytogenetic characterization. Tomasino RM; Morello V; Tralongo V; Nagar C; Nuara R; Daniele E; Curti M; Orestano F Pathologica; 1994 Jun; 86(3):227-33. PubMed ID: 7808790 [TBL] [Abstract][Full Text] [Related]
7. Image analysis of proliferating cell nuclear antigen expression and immunohistochemical profiles in renal cell carcinoma associated with acquired cystic kidney disease: comparison with classic renal cell carcinoma. Khurana KK; Truong LD; Verani RR Mod Pathol; 1998 Apr; 11(4):339-46. PubMed ID: 9578084 [TBL] [Abstract][Full Text] [Related]
8. [Expression of S100 protein in renal cell carcinoma and its relation with P53]. Yang JF; Zhang XY; Qi F Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Jun; 29(3):301-4. PubMed ID: 16136965 [TBL] [Abstract][Full Text] [Related]
9. Differential expression of the enzyme that esterifies retinol, lecithin:retinol acyltransferase, in subtypes of human renal cancer and normal kidney. Zhan HC; Gudas LJ; Bok D; Rando R; Nanus DM; Tickoo SK Clin Cancer Res; 2003 Oct; 9(13):4897-905. PubMed ID: 14581364 [TBL] [Abstract][Full Text] [Related]
10. Tissue expression and plasma levels of adrenomedullin in renal cancer patients. Michelsen J; Thiesson H; Walter S; Ottosen PD; Skøtt O; Jensen BL Clin Sci (Lond); 2006 Jul; 111(1):61-70. PubMed ID: 16515534 [TBL] [Abstract][Full Text] [Related]
11. Differential expression of activator protein-2 isoforms in renal cell carcinoma. Oya M; Mikami S; Mizuno R; Miyajima A; Horiguchi Y; Nakashima J; Marumo K; Mukai M; Murai M Urology; 2004 Jul; 64(1):162-7. PubMed ID: 15245963 [TBL] [Abstract][Full Text] [Related]
12. p53 protein expression in transitional mucosa and adenocarcinomas of the colorectum. Connelly JH; Bruner JM; Robey-Cafferty SS; Sahin A Mod Pathol; 1992 Sep; 5(5):537-9. PubMed ID: 1344817 [TBL] [Abstract][Full Text] [Related]
13. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma. Cruz IB; Snijders PJ; Meijer CJ; Braakhuis BJ; Snow GB; Walboomers JM; van der Waal I J Pathol; 1998 Apr; 184(4):360-8. PubMed ID: 9664901 [TBL] [Abstract][Full Text] [Related]
14. [The role of p53 tumor suppressor gene as prognostic factor in laryngeal squamous cell carcinoma]. Garozzo A; Cutrona D; Palmeri S; Maiolino L; Puzzo L; Allegra E Acta Otorhinolaryngol Ital; 1999 Dec; 19(6):342-7. PubMed ID: 10875157 [TBL] [Abstract][Full Text] [Related]
15. p53 protein expression in a population-based series of primary vulval squamous cell carcinoma and immediate adjacent field change. McConnell DT; Miller ID; Parkin DE; Murray GI Gynecol Oncol; 1997 Dec; 67(3):248-54. PubMed ID: 9441771 [TBL] [Abstract][Full Text] [Related]
16. Value of p53 as a prognostic marker in histologic subtypes of renal cell carcinoma: a systematic analysis of primary and metastatic tumor tissue. Zigeuner R; Ratschek M; Rehak P; Schips L; Langner C Urology; 2004 Apr; 63(4):651-5. PubMed ID: 15072872 [TBL] [Abstract][Full Text] [Related]
17. Expression of p53 in renal carcinoma cells is independent of pVHL. Stickle NH; Cheng LS; Watson IR; Alon N; Malkin D; Irwin MS; Ohh M Mutat Res; 2005 Oct; 578(1-2):23-32. PubMed ID: 15998523 [TBL] [Abstract][Full Text] [Related]
18. Renal papillary adenoma--a putative precursor of papillary renal cell carcinoma. Wang KL; Weinrach DM; Luan C; Han M; Lin F; Teh BT; Yang XJ Hum Pathol; 2007 Feb; 38(2):239-46. PubMed ID: 17056094 [TBL] [Abstract][Full Text] [Related]
19. Expression of p53 and bcl-2 in primary locally confined renal cell carcinomas: no evidence for prognostic significance. Hofmockel G; Wittmann A; Dammrich J; Bassukas ID Anticancer Res; 1996; 16(6B):3807-11. PubMed ID: 9042262 [TBL] [Abstract][Full Text] [Related]